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CASE HISTORY
A 37-year-old woman with learning difficulties was admitted with a two-day history of bloody diarrhoea associated with vague abdominal pains. The clinical, radiological and histological features were those of toxic colitis, for which intensive medical management was unsuccessful. At laparotomy she proved to have a perforated toxic megacolon and a subtotal colectomy and ileostomy was performed. Post- operative recovery was at first satisfactory, but on the ninth postoperative day she became acutely short of breath. Chest X-ray showed consolidation and collapse of the left lower lobe. Continuous positive airway pressure ventilation was started but she tolerated it poorly and had a respiratory arrest requiring intubation and ventilation. Her condition deteriorated further with the development of adult respiratory distress syndrome. In addition, she had bone marrow failure with arrest at the promyelocytic stage associated with a methicillin-resistant Staphylococcus aureus septicaemia.
When first ventilated she was hypokalaemic (K+ 2.3 mmol/L) and normonatraemic (Na+ 136 mmol/L). Over the first 24 h of ventilation serum sodium rose to hypernatraemic levels (Na+ 148 mmol/L) but the hypokalaemia proved difficult to correct (K+ 3.3 mmol/L). She remained hypernatraemic for the next 12 days, reaching a maximum sodium of 156 mmol/L on the ninth day of ventilation.
After aggressive therapy including nitrous oxide, she made a slow recovery. When the sedation was reduced after eight days of ventilation it became apparent that she had developed a flaccid quadriparesis with MRC grade 0 or 1 power, areflexia and equivocal plantar reflexes. Over the next two months she regained motor function to MRC grade 3 or 4. The quadriparesis became spastic with hyperreflexia and clonus. The plantar responses were extensor. In addition she was dyskinesic and ataxic. Magnetic resonance imaging (MRI) (Figure 1 ) showed a pattern characteristic of central pontine myelinolysis.
COMMENT
Central pontine myelinolysis, a rare condition first described in 1959, presents as a quadriparesis with a pseudobulbar palsy together with alteration in the level of consciousness. The principal pathological feature is of myelinolysis within the pons, with or without bilateral extrapontine myelinolysis. The mechanism is obscure, but one precipitating feature seems to be the rapid correction of severe hyponatraemia,1,2 with a rise in serum sodium of greater than 12 mmol/L over 24 h1; but it is the rate of rise that is responsible rather than absolute values3. An increase from normal levels can also lead to myelinolysis4. Concurrent In women with trophoblastic disease or hyperemesis gravidarum, hyperthyroidism due to chorionic gonadotropin (hCG) hypersecretion is commonly identified1'2. In men with hCG-secreting tumours, however, it seems to be rare3-5. We report such a case.
CASE HISTORY
A previously fit 33-year-old man reported abdominal discomfort, backache, anorexia, nausea, vomiting and weight loss. He had a pulse rate of 104 beats per minute and a central abdominal mass. Chest X-ray and ultrasound and computed tomography scans were consistent with metastatic disease involving the lungs, liver and para-aortic lymph nodes. There was no clinical or radiological testicular abnormality. A biopsy of the para-aortic lymph nodes was characteristic of embryonal carcinoma. Serum ,BhCG was 880 000 IU/L (reference range <4). Courses of bleomycin, etoposide and cisplatin monthly for four months led to resolution of symptoms; there was shrinkage of the paraaortic lymphadenopathy and lung metastases and serum PhCG fell to a nadir of 59 100 IU/L. When his fifth course of chemotherapy was postponed because of mild renal impairment, his condition deteriorated rapidly with dyspnoea, anorexia, vomiting and weight loss. He also developed tachycardia, hepatomegaly and gynaecomastia. A rise in serum #hCG confirmed tumour relapse. At this time he had a raised free thyroxine (72.4 pmol/L) and, unusually, a detectable level of thyroid stimulating hormone (TSH). Further investigations confirmed hyperthyroidism, but a different TSH immunoassay gave a suppressed result. The patient died and necropsy was not performed, but thyroid hormones and TSH were measured retrospectively. At presentation he had biochemical evidence of hyperthyroidism which, apart from a suppressed TSH (Amerlite) of <0.05 mU/L, reverted to normal after anti-tumour chemotherapy, but then recurred with tumour relapse (Table 1) .
COMMENT Symptomless hyperthyroidism in men may go unrecognized if it resolves with successful cancer chemotherapy4. Why frank thyrotoxicosis does not always develop in hCGinduced hyperthyroidism is unknown but it may be that rapid tumour growth and hCG-induced thyroid hypersecretion outpaces the effects of thyroid hormone on the tissues.
In our patient, the reversal of hyperthyroidism by tumour chemotherapy and the later development of frank hyperthyroidism following tumour relapse is consistent with the notion that the tumour was causal in the development of hyperthyroidism. The likeliest thyroid stimulator is hCG but this is controversial6. hCG exists as different isoforms, and one suggestion is that desialated variants (produced more abundantly in patients with hCG-induced hyperthyroidism) have greater thyrotropic activity than sialated isoforms7'8
Although patients with hCG-induced hyperthyroidism may present with features typical of thyrotoxicosis, the commonest, and often. the only, presenting sign is tachycardia3-5. Other features of hCG-induced hyperthyroidism include extraordinarily high hCG and oestrogen concentrations, detectable serum 'TSH' levels (probably due to cross-reactivity of very high hCG levels in some TSH immunoassays), gynaecomastia and presence of metastatic disease3-5. Since hCG activity directly correlates with the number of tumour cells present, it is not surprising that high hCG levels reflect widespread and often terminal metastatic disease.
